Cite
HARVARD Citation
Kapp, K. et al. (2019). Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors. Oncoimmunology. p. . [Online].